Yukiko Ozawa

2.0k total citations
54 papers, 557 citations indexed

About

Yukiko Ozawa is a scholar working on Neurology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Yukiko Ozawa has authored 54 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 23 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Yukiko Ozawa's work include Myasthenia Gravis and Thymoma (30 papers), Antifungal resistance and susceptibility (23 papers) and Peripheral Neuropathies and Disorders (20 papers). Yukiko Ozawa is often cited by papers focused on Myasthenia Gravis and Thymoma (30 papers), Antifungal resistance and susceptibility (23 papers) and Peripheral Neuropathies and Disorders (20 papers). Yukiko Ozawa collaborates with scholars based in Japan, Canada and Belgium. Yukiko Ozawa's co-authors include Satoshi Kuwabara, Akiyuki Uzawa, Naoki Kawaguchi, Manato Yasuda, Fumiko Oda, Keiichi Himuro, Shigeaki Suzuki, Yuriko Nagane, Kimiaki Utsugisawa and Yosuke Onishi and has published in prestigious journals such as PLoS ONE, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yukiko Ozawa

49 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukiko Ozawa Japan 14 351 133 104 55 39 54 557
Karissa Gable United States 11 139 0.4× 34 0.3× 165 1.6× 69 1.3× 16 0.4× 23 442
Laura Bărcuţean Romania 12 133 0.4× 33 0.2× 160 1.5× 31 0.6× 32 0.8× 42 528
Jinze Wu China 9 69 0.2× 40 0.3× 104 1.0× 40 0.7× 33 0.8× 12 310
Ryoko Koike Japan 13 186 0.5× 27 0.2× 161 1.5× 62 1.1× 42 1.1× 35 444
Camila Araujo United States 11 183 0.5× 18 0.1× 211 2.0× 45 0.8× 84 2.2× 14 525
Guanzhong Ni China 12 93 0.3× 23 0.2× 143 1.4× 35 0.6× 73 1.9× 24 445
Xianhua Hou China 13 51 0.1× 25 0.2× 118 1.1× 29 0.5× 87 2.2× 18 396
Shin‐Ichi Ueno Japan 11 238 0.7× 12 0.1× 153 1.5× 55 1.0× 100 2.6× 33 486
Kalliopi Marinou Italy 12 472 1.3× 14 0.1× 170 1.6× 117 2.1× 63 1.6× 14 660
Naoki Nakao Japan 9 154 0.4× 17 0.1× 234 2.3× 185 3.4× 58 1.5× 32 445

Countries citing papers authored by Yukiko Ozawa

Since Specialization
Citations

This map shows the geographic impact of Yukiko Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukiko Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukiko Ozawa more than expected).

Fields of papers citing papers by Yukiko Ozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukiko Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukiko Ozawa. The network helps show where Yukiko Ozawa may publish in the future.

Co-authorship network of co-authors of Yukiko Ozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yukiko Ozawa. A scholar is included among the top collaborators of Yukiko Ozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukiko Ozawa. Yukiko Ozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uzawa, Akiyuki, Shigeaki Suzuki, Satoshi Kuwabara, et al.. (2024). Taste disorders and alopecia in myasthenia gravis. BMC Neurology. 24(1). 139–139. 3 indexed citations
2.
Uzawa, Akiyuki, Shigeaki Suzuki, Satoshi Kuwabara, et al.. (2023). Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Neurotherapeutics. 20(2). 518–523. 5 indexed citations
3.
Uzawa, Akiyuki, Yuta Kojima, Yukiko Ozawa, et al.. (2023). Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis. Journal of Neuroimmunology. 375. 578014–578014. 3 indexed citations
4.
Yasuda, Manato, Akiyuki Uzawa, Satoshi Kuwabara, et al.. (2023). Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan. Journal of Neuroimmunology. 385. 578241–578241. 3 indexed citations
5.
Uzawa, Akiyuki, Shigeaki Suzuki, Satoshi Kuwabara, et al.. (2023). Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 467–473. 35 indexed citations
6.
Uzawa, Akiyuki, et al.. (2023). Minimal symptom expression achievement over time in generalized myasthenia gravis. Acta Neurologica Belgica. 123(3). 979–982. 8 indexed citations
7.
Kojima, Yuta, Kazumoto Shibuya, Akiyuki Uzawa, et al.. (2022). Decreased initial compound muscle action potential amplitudes in myasthenia gravis. Neurology and Clinical Neuroscience. 10(5). 245–251.
8.
Kojima, Yuta, Kazumoto Shibuya, Akiyuki Uzawa, et al.. (2021). Dispersion of mean consecutive differences in single‐fiber electromyography increases diagnostic sensitivity for myasthenia gravis. Muscle & Nerve. 63(6). 885–889. 2 indexed citations
9.
Yasuda, Manato, Akiyuki Uzawa, Yukiko Ozawa, et al.. (2021). Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis. Scandinavian Journal of Immunology. 95(2). e13122–e13122. 2 indexed citations
10.
Uzawa, Akiyuki, Yuta Kojima, Yukiko Ozawa, et al.. (2021). High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis. Journal of Neuroimmunology. 358. 577634–577634. 25 indexed citations
11.
Uzawa, Akiyuki, Yukiko Ozawa, Manato Yasuda, et al.. (2019). Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis. Journal of Neuroimmunology. 339. 577125–577125. 3 indexed citations
12.
Uzawa, Akiyuki, Tetsuya Kanai, Naoki Kawaguchi, et al.. (2016). Relationship between damage‐associated molecular patterns and cytokines in myasthenia gravis. Clinical and Experimental Neuroimmunology. 7(4). 357–360. 1 indexed citations
13.
14.
Ozawa, Yukiko, Yasufumi Takahashi, Akio Urushiyama, et al.. (2012). Indolepyruvate ferredoxin oxidoreductase: An oxygen-sensitive iron–sulfur enzyme from the hyperthermophilic archaeon Thermococcus profundus. Journal of Bioscience and Bioengineering. 114(1). 23–27. 11 indexed citations
15.
Ozawa, Yukiko, Yuko Ueno, Y. Morimoto, et al.. (2011). Cyanidioschyzon merolae ferredoxin: A high resolution crystal structure analysis and its thermal stability. FEBS Letters. 585(9). 1299–1302. 6 indexed citations
16.
Akiyama, Takamasa, et al.. (2010). Destination Choice Model with Fuzzy Classifier System for Transport Planning. Journal of Japan Society for Fuzzy Theory and Intelligent Informatics. 22(1). 110–120.
17.
Ozawa, Yukiko. (1998). Strategies for the Control of Surra in Asia. Obihiro University of Agriculture and Veterinary Medicine Institutional Repository. 8(3). 103–105. 1 indexed citations
18.
Yamaguchi, Takashi, Yukiko Ozawa, M. Suzuki, et al.. (1996). Indeloxazine hydrochloride improves impairment of passive avoidance performance after fluid percussion brain injury in rats. Neuropharmacology. 35(3). 329–336. 11 indexed citations
19.
Yamamoto, Minoru, Yukiko Ozawa, Masao Sasamata, Noriaki Koshikawa, & Masafumi Kobayashi. (1990). Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents. European Journal of Pharmacology. 180(2-3). 319–324. 4 indexed citations
20.
Yamamoto, Minoru, et al.. (1989). Effects of indeloxamine hydrochloride on passive avoidance behavior of senescence-accelerated mice. European Journal of Pharmacology. 166(2). 345–348. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karissa Gable Breakdown of academic impact, for papers by Laura Bărcuţean Breakdown of academic impact, for papers by Jinze Wu Breakdown of academic impact, for papers by Ryoko Koike Breakdown of academic impact, for papers by Camila Araujo Breakdown of academic impact, for papers by Guanzhong Ni Breakdown of academic impact, for papers by Xianhua Hou Breakdown of academic impact, for papers by Shin‐Ichi Ueno Breakdown of academic impact, for papers by Kalliopi Marinou Breakdown of academic impact, for papers by Naoki Nakao
Rankless by CCL
2026